ranibizumab 0.5 mg
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ranibizumab 0.5 mg, covering 2018-02-12 to 2019-06-24. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia [Phase 3]